Yayınlar & Eserler

Yayın Ağı
Makaleler 39
Tümü (39)
SCI-E, SSCI, AHCI (35)
SCI-E, SSCI, AHCI, ESCI (36)
ESCI (1)
Scopus (36)
TRDizin (6)

1. Optimization of Semi-Solid Lipid Nanoparticle Dispersions by Quality by Design Approach for Dermal Delivery of Curcumin

BADILLI F. U., Sen A., Yegen G., GÜVEN ÇİLOĞLU B., Aksu B., Onay Besikci A.
Journal of Cluster Science , cilt.36, sa.5, 2025 (SCI-Expanded) Creative Commons License identifier identifier

2. Past and present of beta arrestins: A new perspective on insulin secretion and effect.

GÜVEN B., Onay-Besikci A.
European journal of pharmacology , cilt.956, ss.175952, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

3. SARS-CoV-2 Infection may be Prevented with Cytochrome Inhibitors: Cobicistat and Ritonavir

Gülten E., Çelik İ., Beşikci A., Çınar G., Akdemir Kalkan İ., Kılcıgil G., et al.
Infectious diseases and clinical microbiology (Online) , cilt.4, sa.3, ss.185-191, 2022 (Hakemli Dergi) identifier

4. A no-filter snapshot of drug-related problems in Ankara University Hospitals

TEZGELEN A. S., KAYRA T., ÜRKMEZ F., Akyol B., TOPALOĞLU İ. E., RAHVAN H., et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.44, sa.3, ss.797, 2022 (SCI-Expanded) identifier

5. Pleiotropic vascular effects of ivabradine in streptozotocin-induced diabetes

Kara Z., GÜVEN B., BEŞİKCİ A., YILDIRIM N., ALTUNAY H.
EUROPEAN JOURNAL OF PHARMACOLOGY , cilt.916, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

6. Synthesis, molecular docking, in silico ADME, and EGFR kinase inhibitor activity studies of some new benzimidazole derivatives bearing thiosemicarbazide, triazole, and thiadiazole

ÇELİK İ., Ayhan-Kilcigil G., Karayel A., GÜVEN B., BEŞİKCİ A.
JOURNAL OF HETEROCYCLIC CHEMISTRY , cilt.59, sa.2, ss.371-387, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

7. HİPERTANSİYON TEDAVİ YÖNETİMİNDE ECZACININ ROLÜ: AİLE SAĞLIĞI MERKEZİ’NDE BİR MODEL UYGULAMASI

PEHLİVANLI A., Akyol B., Sesyılmaz Ö., Göçün Ö., BEŞİKCİ A., ÖZÇELİKAY A. T., et al.
Journal of Faculty of Pharmacy of Ankara University , cilt.45, sa.1, ss.1-11, 2021 (Scopus) identifier identifier

8. Pattern of systemic antibiotic use and potential drug interactions: evaluations through a point prevalence study in Ankara University Hospitals

AKDEMİR KALKAN İ., ÇINAR G., PEHLİVANLI A., ÜRKMEZ F., TOPALOĞLU İ. E., Akyol B., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.2, ss.523-529, 2021 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier identifier

9. Metabolic effects of carvedilol through beta-arrestin proteins: investigations in a streptozotocin-induced diabetes rat model and in C2C12 myoblasts

GÜVEN B., Kara Z., BEŞİKCİ A.
BRITISH JOURNAL OF PHARMACOLOGY , cilt.177, sa.24, ss.5580-5594, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

10. Design, synthesis and docking studies of benzimidazole derivatives as potential EGFR inhibitors

ÇELİK İ., KILCIGİL G., GÜVEN B., Kara Z., Gurkan-Alp A. S., KARAYEL A., et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , cilt.173, ss.240-249, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

11. QbD guided early pharmaceutical development study: Production of lipid nanoparticles by high pressure homogenization for skin cancer treatment

AMASYA G., Aksu B., BADILLI F. U., BEŞİKCİ A., Tarimci N.
INTERNATIONAL JOURNAL OF PHARMACEUTICS , cilt.563, ss.110-121, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

12. Orbital Cellulitis Accompanied by a Non-Symptomatic Drug Interaction That Promptly Responded to Drug Modification

AKDEMİR K. İ., AKYOL B., YILMAZ F., BEŞİKCİ A., MEMİKOĞLU K. O.
Turkiye Klinikleri Journal of Case Reports , cilt.27, sa.2, ss.95-98, 2019 (Hakemli Dergi)

13. THERMOSENSITIVE IN SITU GEL FORMULATION CONTAINING PLGA NANOPARTICLES OF FLURBIPROFEN FOR OCULAR DELIVERY

Aydin E., BADILLI F. U., BEŞİKCİ A., Tarimci N.
ACTA POLONIAE PHARMACEUTICA , cilt.75, sa.1, ss.141-153, 2018 (SCI-Expanded, Scopus) identifier identifier

14. Synthesis and Pharmacologic Evaluation of Some Benzimidazole Acetohydrazide Derivatives as EGFR Inhibitors

Demirel S., KILCIGİL G., Kara Z., GÜVEN B., BEŞİKCİ A.
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.14, sa.3, ss.285-289, 2017 (ESCI, Scopus, TRDizin) identifier identifier identifier

15. Evaluation of three-layered doxycycline-collagen loaded nanofiber wound dressing

TORT S., ACARTÜRK F., BEŞİKCİ A.
INTERNATIONAL JOURNAL OF PHARMACEUTICS , cilt.529, sa.1-2, ss.642-653, 2017 (SCI-Expanded, Scopus) identifier identifier identifier

16. Skin Localization of Lipid Nanoparticles (SLN/NLC): Focusing the Influence of Formulation Parameters

AMASYA G., Sandri G., BEŞİKCİ A., BADILLI F. U., Caramella C., Bonferoni M. C., et al.
CURRENT DRUG DELIVERY , cilt.13, sa.7, ss.1100-1110, 2016 (SCI-Expanded, Scopus) identifier identifier identifier

17. Calcipotriol-captisol inclusion complex and corticosteroid in a novel fixed dose combination: evaluation on human epidermal keratinocyte cells

BADILLI F. U., BEŞİKCİ A., AMASYA G., Sen T., Tarimci N.
JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY , cilt.83, sa.3-4, ss.363-368, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

18. Activating PPAR alpha Prevents Post-Ischemic Contractile Dysfunction in Hypertrophied Neonatal Hearts

Lam V. H., Zhang L., Huqi A., Fukushima A., Tanner B. A., BEŞİKCİ A., et al.
CIRCULATION RESEARCH , cilt.117, sa.1, ss.41-51, 2015 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

19. Effect of Fatty Acids on Human Bone Marrow Mesenchymal Stem Cell Energy Metabolism and Survival

Fillmore N., Huqi A., Jaswal J. S., Mori J., Paulin R., Haromy A., et al.
PLOS ONE , cilt.10, sa.3, 2015 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

20. Paclitaxel-loaded niosomes for intravenous administration: pharmacokinetics and tissue distribution in rats

SEZGİN BAYINDIR Z., BEŞİKCİ A., YÜKSEL N.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.45, sa.6, ss.1403-1412, 2015 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier

21. Development of Etofenamate-Loaded Semisolid SLN Dispersions and Evaluation of Anti-Inflammatory Activity for Topical Application

BADILLI F. U., ŞENGEL TÜRK C. T., BEŞİKCİ A., Tarimci N.
CURRENT DRUG DELIVERY , cilt.12, sa.2, ss.200-209, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

22. Substrate Metabolism in the Diabetic Heart

BEŞİKCİ A.
DIABETIC CARDIOMYOPATHY: BIOCHEMICAL AND MOLECULAR MECHANISMS , cilt.9, ss.65-76, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

23. Synthesis, biological evaluation and docking studies of new pyrrolo[2,3-d] pyrimidine derivatives as Src family-selective tyrosine kinase inhibitors

Dincer S., Cetin K. T., BEŞİKCİ A., Olgen S.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY , cilt.28, sa.5, ss.1080-1087, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

24. Synthesis, Biological and Computational Evaluation of Novel Oxindole Derivatives as Inhibitors of Src Family Kinases

KILIÇ KURT Z., BEŞİKCİ A., Olgen S.
LETTERS IN DRUG DESIGN & DISCOVERY , cilt.10, sa.8, ss.713-718, 2013 (SCI-Expanded, Scopus) identifier identifier

25. Special Issue: New Trends in Pharmaceutical Sciences 10th International Symposium on Pharmaceutical Sciences (10th ISOPS) June 26 to 29, 2012 Ankara University Faculty of Pharmacy, Ankara-Turkey

YÜKSEL N., BEŞİKCİ A.
CURRENT DRUG DELIVERY , cilt.10, sa.1, ss.2, 2013 (SCI-Expanded, Scopus) identifier

26. Niosomes encapsulating paclitaxel for oral bioavailability enhancement: preparation, characterization, pharmacokinetics and biodistribution

SEZGİN BAYINDIR Z., BEŞİKCİ A., VURAL N., YÜKSEL N.
JOURNAL OF MICROENCAPSULATION , cilt.30, sa.8, ss.796-804, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

27. Carvedilol suppresses fatty acid oxidation and stimulates glycolysis in C2C12 cells

BEŞİKCİ A., Suzmecelik E., ÖZÇELİKAY A. T.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY , cilt.90, sa.8, ss.1087-1093, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

28. Acute Regulation of Cardiac Metabolism by the Hexosamine Biosynthesis Pathway and Protein O-GlcNAcylation

Laczy B., Fueloep N., BEŞİKCİ A., Rosiers C. D., Chatham J. C.
PLOS ONE , cilt.6, sa.4, 2011 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

29. Protective action of doxycycline against diabetic cardiomyopathy in rats

YARAŞ N., Sariahmetoglu M., BİLGİNOĞLU A., Aydemir-Koksoy A., BEŞİKCİ A., Turan B., et al.
BRITISH JOURNAL OF PHARMACOLOGY , cilt.155, sa.8, ss.1174-1184, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

30. Trimetazidine revisited: A comprehensive review of the pharmacological effects and analytical techniques for the determination of trimetazidine

BEŞİKCİ A., Oezkan S. A.
Cardiovascular Therapeutics , cilt.26, sa.2, ss.147-165, 2008 (SCI-Expanded, Scopus) identifier identifier identifier

31. alpha-Lipoic acid increases cardiac glucose oxidation independent of AMP-activated protein kinase in isolated working rat hearts

BEŞİKCİ A., Wagg C., Lopaschuk T. P., Keung W., Lopaschuk G. D.
BASIC RESEARCH IN CARDIOLOGY , cilt.102, sa.5, ss.436-444, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

32. The effects of chronic trimetazidine treatment on mechanical function and fatty acid oxidation in diabetic rat hearts

BEŞİKCİ A., Guner S., Arioglu E., ÖZAKCA GÜNDÜZ I., ÖZÇELİKAY A. T., Altan V. M.
Canadian Journal of Physiology and Pharmacology , cilt.85, sa.5, ss.527-535, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

33. Impact of lactate in the perfusate on function and metabolic parameters of isolated working rat heart

BEŞİKCİ A.
MOLECULAR AND CELLULAR BIOCHEMISTRY , cilt.296, sa.1-2, ss.121-127, 2007 (SCI-Expanded, Scopus) identifier identifier identifier

34. The effects of chronic trimetazidine treatment on mechanical parameters and fatty acid oxidation in 14-week diabetic rat hearts

BEŞİKCİ A., Guner S., Arioglu E., ÖZAKCA GÜNDÜZ I., Ozcelikay T., Altan V. M.
CARDIOVASCULAR DRUGS AND THERAPY , cilt.20, sa.6, ss.417, 2006 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

35. Substrate metabolism and function of fructose-fed rat heart

Guner S., BEŞİKCİ A., Arioglu E., ÖZAKCA GÜNDÜZ I., Altan V. M., ÖZÇELİKAY A. T.
CARDIOVASCULAR DRUGS AND THERAPY , cilt.20, sa.6, ss.408, 2006 (SCI-Expanded) identifier

36. Malonyl CoA control of fatty acid oxidation in the newborn heart in response to increased fatty acid supply

BEŞİKCİ A., Sambandam N.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY , cilt.84, sa.11, ss.1215-1222, 2006 (SCI-Expanded, Scopus) identifier identifier identifier

37. Regulation of cardiac energy metabolism in newborn

BEŞİKCİ A.
MOLECULAR AND CELLULAR BIOCHEMISTRY , cilt.287, sa.1-2, ss.1-11, 2006 (SCI-Expanded, Scopus) identifier identifier identifier

38. gAd-globular head domain of adiponectin increases fatty acid oxidation in newborn rabbit hearts

BEŞİKCİ A., Altarejos J., Lopaschuk G.
JOURNAL OF BIOLOGICAL CHEMISTRY , cilt.279, sa.43, ss.44320-44326, 2004 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

39. Potential mechanisms and consequences of cardiac triacylglycerol accumulation in insulin-resistant rats

Atkinson L., Kozak R., Kelly S., BEŞİKCİ A., Russell J., Lopaschuk G.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM , cilt.284, sa.5, 2003 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 42

1. Chronic Effects of Carvedilol on Erectile Dysfunction in STZ-Induced Diabetic Rats

GÜVEN ÇİLOĞLU B., YILMAZ ORAL D., KARA Z., GÜR S., BEŞİKCİ A.
14. Uluslararası Tıp ve Sağlık Bilimleri Araştırmaları Kongresi- UTSAK, Ankara, Türkiye, 23 - 24 Aralık 2023, (Özet Bildiri)

2. Monitoring vancomycin plasma levels: Pharmacokinetic evaluations andcompliance with guidelines

Kahraman Başer S., Topaloğlu I. E., Çinar G., Gülten E., Akdemir Kalkan I., Saricaoğlu E. M., et al.
NORPM2023, Turku, Finlandiya, 14 - 16 Haziran 2023, ss.11, (Özet Bildiri)

3. Potential drug interactions in hospitalized patients: Are the evaluations coherent?

Topaloğlu I. E., Beşikci A.
NORPM2023, Turku, Finlandiya, 14 - 16 Haziran 2023, ss.11, (Özet Bildiri)

4. Metabolic Effects of Carvedilol on Control and HFpEF Mouse Heart and Hypertrophied H9c2 Cells: The Potential Contribution of a Biased Agonist Effect

GÜVEN B., QIUYU S., PERSAD K. L., WAGG C., OLIVEIRA A. A., SILVER H., et al.
ECCR 2022, Treviso, İtalya, 30 Eylül - 02 Ekim 2022, (Özet Bildiri)

5. The direct metabolic effects of carvedilol in control mice hearts and hypertrophied H9c2 cells

GÜVEN B., WAGG C. S., PERSAD K. L., SUN Q., ANDRE D. J., BEŞİKCİ A., et al.
Pediatrics Research Day, Edmonton, Kanada, 06 Nisan 2022, (Özet Bildiri)

6. IN VIVO EVALUATION ON FLUTICASONE PROPIONATE LOADED SEMI-SOLID LIPID NANOPARTICLE DISPERSIONS

BADILLI F. U., ŞENGEL TÜRK C. T., AMASYA G., ALÇIĞIR M. E., BEŞİKCİ A., AKSU N. B., et al.
20th International Pharmaceutical Technology Symposium – IPTS 2022, Ankara, Türkiye, 21 - 23 Şubat 2022, (Özet Bildiri)

7. SARS-CoV-2 İnfeksiyonu Sitokrom İnhibitörleri Kobisistat ve Ritonavirle Önleniyor Olabilir mi?

ÇELİK İ., GÜLTEN E., BEŞİKCİ A., ÇINAR G., AKDEMİR KALKAN İ., KILCIGİL G., et al.
KLİMİK Covid-19 Simpozyumu, İstanbul, Türkiye, 10 - 12 Eylül 2021, (Özet Bildiri)

8. CURCUMIN LOADED SEMISOLID SLN DISPERSIONS: FORMULATION OPTIMIZATION AND IN VIVO EVALUATION

KARGILI ŞEN A., BADILLI F. U., YEĞEN G., GÜVEN B., AKSU N. B., BEŞİKCİ A.
13th International Symposium on Pharmaceutical Sciences (ISOPS-13), Türkiye, 22 Haziran 2021, (Özet Bildiri)

9. Semisolid NLC dispersions: QbD based formulation optimization and ex vivo – in vivo evaluation

AMASYA G., ŞENGEL TÜRK C. T., BADILLI F. U., AKSU N. B., BEŞİKCİ A., TARIMCI M. N.
EUFEPS Virtual Annual Meeting 2021 – Bridging the gap between the patient and product design, İsveç, 7 - 09 Haziran 2021, (Özet Bildiri)

10. Design and Synthesis of Some Oxadiazole Bearing Benzimidazole Derivatives as PotentialEpidermal Growth Factor Receptor (EGFR) Inhibitors

ÇELİK İ., KILCIGİL G., GÜVEN B., BEŞİKCİ A., Kara Z.
ICMBC 2019 : International Conference onMedicinal and Biological Chemistry, Barselona, İspanya, 15 - 16 Ağustos 2019, (Özet Bildiri)

11. Metabolic effects of carvedilol through β-arrestin-2: investigations in cells and streptozotocin-diabetic rats

GÜVEN B., KARA Z., BEŞİKCİ A.
17th Annual Meeting of the Society for Heart and Vascular Metabolism (SHVM), 23 - 26 Haziran 2019, (Özet Bildiri) Sürdürülebilir Kalkınma

12. Presence of HCN Channels in Rat Aorta and Prevention of Endothelial Dysfunction with Their Selective Inhibitor Ivabradine

kara z., GÜVEN B., BEŞİKCİ A.
Pharmacology 2018, Londrina, Brezilya, 17 - 19 Aralık 2018, (Özet Bildiri)

13. Synthesis of Some Thiadiazole/Triazole Linked1H-Benzimidazole Derivatives As Inhibitors of EGFR Tyrosine Kinase

ÇELİK İ., KILCIGİL G., BEŞİKCİ A., kara z., GÜVEN B.
Eczacılık Kongre ve Fuarı, Paris, Fransa, 20 - 21 Ağustos 2018, (Özet Bildiri)

14. THE EFFECT OF CARVEDILOL TREATMENT ON ERECTILE DYSFUNCTION IN STREPTOZOTOCIN INDUCED DIABETIC RATS.

YILMAZ D., GÜVEN B., KARA Z., GÜR S., BEŞİKCİ A.
12th INTERNATIONAL SYMPOSIUM ON PHARMACEUTICAL SCIENCES, Ankara, Türkiye, 26 - 29 Haziran 2018, (Özet Bildiri) Sürdürülebilir Kalkınma

15. THE POSSIBLE BENEFICIAL EFFECT OF IVABRADINE TREATMENT ON ERECTILE TISSUE IN A DIABETIC RAT MODEL

YILMAZ D., KARA Z., GÜVEN B., BEŞİKCİ A., GÜR S.
12th INTERNATIONAL SYMPOSIUM ON PHARMACEUTICAL SCIENCES, Ankara, Türkiye, 26 - 29 Haziran 2018, (Özet Bildiri) Sürdürülebilir Kalkınma

16. The mechanism of acute and chronic vascular effects of ivabradine in control and diabetic rats

Kara Z., Guven B., BEŞİKCİ A.
5th Congress of the ESC-Council-on-Basic-Cardiovascular-Science on Frontiers in Cardio Vascular Biology, Vienna, Avusturya, 20 - 22 Nisan 2018, cilt.114, (Özet Bildiri) Creative Commons License Sürdürülebilir Kalkınma identifier

17. Therapeutic effect of carvedilol on cardiac function in streptozotocin-diabetic rats

Guven B., Kara Z., BEŞİKCİ A.
5th Congress of the ESC-Council-on-Basic-Cardiovascular-Science on Frontiers in Cardio Vascular Biology, Vienna, Avusturya, 20 - 22 Nisan 2018, cilt.114, (Özet Bildiri) Creative Commons License Sürdürülebilir Kalkınma identifier

18. SYNTHESIS OF SOME 1H-BENZIMIDAZOLES CONTAINING CYCLOHEXYL SUBSTITUTED THIOSEMICARBAZIDES, TRIAZOLES, THIADIAZOLES AS INHIBITORS OF EGFR TYROSINE KINASE

ÇELİK İ., KILCIGİL G., Kara Z., GÜVEN B., BEŞİKCİ A.
GPSS2017, 11 - 13 Ekim 2017, (Özet Bildiri)

19. Investigation of the Pleiotropic Vascular Effects of Ivabradine in Control and Diabetic Rats

Kara Z., GÜVEN B., BEŞİKCİ A.
20th Annual Meeting of European Council for Cardiovascular Resarch, ECCR, Verona, İtalya, 14 - 16 Ekim 2016 Sürdürülebilir Kalkınma

20. The effect of leptin treatment on in vivo cardiac parameters of streptozotocin induced diabetic rats

ARIOĞLU İNAN E., ERDOĞAN B. R., Müderrisoğlu E., KARAÖMERLİOĞLU İ., KAYKI MUTLU G., BEŞİKCİ A., et al.
9th Annual Meeting of the Diabetes and Cardiovascular Disease, 30 Haziran - 02 Temmuz 2016, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

21. Timolol improves vascular dysfunction via inhibition of oxidative stresss in DOCAsalt hypertensive rats

ÇİÇEK M., ÖZİŞ S. E., ÖZAKCA I., BEŞİKCİ A., ÖZÇELİKAY A. T.
7th European Congress of Pharmacology (EPHAR 2016), İstanbul, Türkiye, 26 - 30 Haziran 2016, (Özet Bildiri)

22. Timolol improves vascular dysfunction via inhibition of oxidative stress in DOCA salt hypertensive rats

çiçek m., Özakça I., Erpulat Öziş S., BEŞİKCİ A., ÖZÇELİKAY A. T.
EPHAR 2016, İstanbul, Türkiye, 26 - 30 Haziran 2016, (Özet Bildiri)

23. Synthesis of Some 1h Benzimidazoles as Inhibitors of EGFR Tyrosine Kinase

ÇELİK İ., BEŞİKCİ A., KILCIGİL G.
World Academy of Science, Engineering and Technology, 27 Haziran 2015 - 28 Haziran 2016

24. Lipid Nanoparticle Based Carbopol Gel for Topical Chemotherapy of 5 Fluorouracil

AMASYA G., BADILLI F. U., BEŞİKCİ A., TARIMCI M. N.
Skin Forum, Londrina, Brezilya, 21 - 22 Haziran 2016

25. In vitro antipsoriatic activity of fixed-dose combination of calcipotriol and clobetasol propionate

BADILLI F. U., BEŞİKCİ A., AMASYA G., ŞEN A. T., TARIMCI M. N.
AAPS Annual Meeting and Exposition, San Diego, Amerika Birleşik Devletleri, 2 - 06 Kasım 2014, (Özet Bildiri)

26. Qualitative and quantitative skin effects of lipid nanoparticles

AMASYA G., SANDRI G., BEŞİKCİ A., BADILLI F. U., CARAMELLA C., BONFERONI M. C., et al.
AAPS Annual Meeting and Exposition, San Diego, Amerika Birleşik Devletleri, 2 - 06 Kasım 2014, (Özet Bildiri)

27. Inhibition of cyclooxygenase 1 enzyme by flurbiprofen loaded ophthalmic nanoparticles

AYDIN E., BEŞİKCİ A., BADILLI F. U., TARIMCI M. N.
Pharmaceutical Sciences World Congress (PSWC 2014), Melbourne, Avustralya, 13 - 16 Nisan 2014

28. Niosomes as drug delivery system for cancer therapy

YÜKSEL N., SEZGİN BAYINDIR Z., BEŞİKCİ A., VURAL N.
International Multidisciplinary Symposium on Drug Research & Development, 28 - 30 Kasım 2013 Sürdürülebilir Kalkınma

29. Sythesis, Biological and Computational Evaluation of Novel N-(3-Substituted-benzylidene-2-oxoindolin-5-yl) acetamide Derivatives As Inhibitors of c-Src Tyrosine Kinase

KILIÇ KURT Z., BEŞİKCİ A., ÖLGEN S.
10th International Symposium on Pharmaceutical Sciences, Ankara, Türkiye, 26 - 29 Haziran 2012, ss.186, (Özet Bildiri)

30. Oral paclitaxel delivery with niosomes

SEZGİN BAYINDIR Z., BEŞİKCİ A., YÜKSEL N.
International Symposium on Pharmaceutical Sciences ISOPS 10th, 26 - 29 Haziran 2012

31. Synthesis, Biological and Computational Evaluation of Novel 1,3,5-Substituted Indolin-2-one Derivatives as Inhibitors of Src Family Kinases

KILIÇ KURT Z., BEŞİKCİ A., ÖLGEN S.
7th Eurasian Meeting On Heterocyclic Chemistry, İstanbul, Türkiye, 17 - 21 Haziran 2012, ss.73, (Özet Bildiri)

32. Niosomes for paclitaxel delivery

SEZGİN BAYINDIR Z., BEŞİKCİ A., YÜKSEL N.
17th International Symposium on Biomedical Science and Technology (BIOMED), 23 - 25 Kasım 2011

33. Niosomal Paclitaxel Development characterization and in vivo comparision with marketed formulation

SEZGİN BAYINDIR Z., BEŞİKCİ A., YÜKSEL N.
3rdPharmsciFair, 13 Haziran 2011

34. Glucosamine increases hexosamine biosynthesis and O-linked N-acetylglucosamine in the heart, and leads to metabolic alterations similar to those seen in diabetic cardiomyopathy

Fulop N., Laczy B., BEŞİKCİ A., Des Rosiers C., Marchase R. B., Chatham J. C.
45th Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Vienna, Avusturya, 30 Eylül - 02 Ekim 2009, cilt.52, (Özet Bildiri) identifier

35. The Effect of Carvedilol on Substrate Metabolism in C2C12 Cells

BEŞİKCİ A., ÖZÇELİKAY A. T., Süzmeçelik E., İrat A. M.
Heart Failure, Nice, Fransa, 30 Mayıs - 02 Haziran 2009

36. Regulation of cardiac substrate utilization by protein O-glycosylation

Fulop N., BEŞİKCİ A., Marchase R. B., Chatham J. C.
19th World Congress of the International-Society-for-Heart-Research, Bologna, İtalya, 22 - 25 Haziran 2007, cilt.42, (Özet Bildiri) identifier

37. Inhibition of matrix metalloproteinases reduces streptozotocin-induced diabetic cardiomyopathy

Sariahmetoglu M., Koksoy A., BİLGİNOĞLU A., BEŞİKCİ A., Turan B., Schulz R.
19th World Congress of the International-Society-for-Heart-Research, Bologna, İtalya, 22 - 25 Haziran 2007, cilt.42, (Özet Bildiri) identifier

38. The Effects of Prediabetes on Responsiveness and Expression of Cardiac Beta-adrenoceptors

GÜNER Ş., ARIOĞLU İNAN E., ÖZAKCA GÜNDÜZ I., BEŞİKCİ A., ALTAN V. M., ÖZÇELİKAY A. T.
2nd International Congress on Prediabetes and the Metabolic Syndrome., 25 - 28 Nisan 2007, (Özet Bildiri)

39. Substrate Metabolism and Function of Fructose-fed rat heart

GÜNER Ş., BEŞİKCİ A., ARIOĞLU İNAN E., ÖZAKCA GÜNDÜZ I., ALTAN V. M., ÖZÇELİKAY A. T.
Society for Heart and Vascular Metabolism. 4th Annual Metting, 6 - 09 Eylül 2006, (Özet Bildiri)

40. The effects of chronic trimetazidine treatment on mechanical parameters and fatty acid oxidation in 14 week diabetic rat hearts

BEŞİKCİ A., GÜNER Ş., ARIOĞLU İNAN E., ÖZAKCA GÜNDÜZ I., ÖZÇELİKAY A. T., ALTAN V. M.
Society for Heart and Vascular Metabolism. 4th Annual Metting, 6 - 09 Eylül 2006, (Özet Bildiri) Sürdürülebilir Kalkınma

41. gAd-globular head domain of adiponectin increases fatty acid oxidation in newborn rabbit hearts

BEŞİKCİ A., Lopaschuk G.
25th Annual Meeting of the North American Section of the International-Society-for-Heart-Research, Connecticut, Amerika Birleşik Devletleri, 28 Haziran - 01 Temmuz 2003, cilt.35, (Özet Bildiri) identifier

42. The gAd-globular head domain of adiponectin improves mechanical function of the rabbit heart by stimulating glucose oxidation

BEŞİKCİ A., Altarejos J., Lopaschuk G.
American-Heart-Association Abstracts From Scientific Sessions, CHICAGO, ILLINOIS, 17 - 20 Kasım 2002, cilt.106, ss.262, (Özet Bildiri) identifier
Kitaplar 6

1. Beta Arrestin

BEŞİKCİ A., GÜVEN B.
Kalp Yetersizliği ve Tedavisinde Yeni Hedefler, , Editör, Tükiye Klinikleri, ss.159-161, 2023

2. Herpes Enfeksiyonlarında Kullanılan İlaçlar

GÜVEN B., ARSLAN E., BEŞİKCİ A.
Viral Enfeksiyonlarda Güncel Tedavi Yaklaşımları ve İmmünizasyon, Erdinç Meral, Editör, Ortadoğu, Ankara, ss.61-68, 2021

3. C Vitamini, D Vitamini, Çinko: COVID-19 Tedavisinde Mikro Besinlerden Makro Beklenti Gerçekçi mi?

GÜVEN B., Kara Z., BEŞİKCİ A.
Türkiye Klinikleri, Birengel Serhat, Balık İsmail, Editör, Ortadoğu, Ankara, ss.53-58, 2021

4. Türk Farmakopesi II - Avrupa Farmakopesi Adaptasyonu

YÜKSEL N., ÖZKAN S. A., ÖZKAN Y., KILIÇARSLAN M., SÜZEN S., SALTAN H. G., et al.
Anıl Reklam Matbaa Ltd. Şti. / Ankara, 2016

5. Substrate Metabolism in the Diabetic Heart

Onay-Besikci A.
Diabetic Cardiomyopathy, Belma Turan and Naranjan S. Dh, Editör, Springer, London/Berlin , New York, ss.65-76, 2013

6. Regulation of Fatty Acid Oxidation by Malonyl CoA in Cardiac Muscle Tissue

Onay-Besikci A., Lopaschuk G. D.
Advances in Molecular and Cell Biology, G. van der Vusse, Editör, Elsevier Science, Oxford/Amsterdam , Amsterdam, ss.223-241, 2003
Metrikler

Yayın

87

Yayın (WoS)

43

Yayın (Scopus)

36

Atıf (WoS)

845

H-İndeks (WoS)

16

Atıf (Scopus)

827

H-İndeks (Scopus)

15

Atıf (TrDizin)

3

H-İndeks (TrDizin)

1

Atıf (Diğer Toplam)

3

Proje

14

Tez Danışmanlığı

3

Açık Erişim

9
BM Sürdürülebilir Kalkınma Amaçları